Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.520
-0.290 (-6.04%)
Dec 3, 2024, 12:16 PM EST - Market open
Aquestive Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -35.19 | -7.87 | -54.41 | -70.54 | -55.78 | -66.25 | Upgrade
|
| Depreciation & Amortization | 1.07 | 1.37 | 2.55 | 3.15 | 3.61 | 3.05 | Upgrade
|
| Other Amortization | 9.81 | 1.97 | 0.22 | 3.73 | 2.59 | 1.93 | Upgrade
|
| Stock-Based Compensation | 5.64 | 2.69 | 4.38 | 6.82 | 6.58 | 7.07 | Upgrade
|
| Other Operating Activities | 0.81 | 0.8 | 5.46 | 25.59 | 1.96 | 5.11 | Upgrade
|
| Change in Accounts Receivable | -1.12 | -3.07 | 7.35 | -5.35 | 6.18 | -6.82 | Upgrade
|
| Change in Inventory | 0.06 | -0.99 | -1.74 | -1.58 | 0.4 | 2.58 | Upgrade
|
| Change in Accounts Payable | -0.92 | -1.02 | 1.63 | 1.23 | -2.21 | -7.13 | Upgrade
|
| Change in Unearned Revenue | -14.06 | 0.97 | 25.04 | 3.56 | -0.83 | 1.6 | Upgrade
|
| Change in Other Net Operating Assets | -0.3 | -1.23 | -0.31 | 0.41 | -7.95 | -1.37 | Upgrade
|
| Operating Cash Flow | -34.21 | -6.38 | -9.82 | -32.98 | -45.46 | -60.21 | Upgrade
|
| Capital Expenditures | -0.16 | -1 | -1.02 | -0.91 | -0.52 | -0.66 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -1.5 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.16 | -1 | -2.52 | -0.91 | -0.52 | -0.66 | Upgrade
|
| Long-Term Debt Issued | - | 31.14 | - | - | - | 70 | Upgrade
|
| Long-Term Debt Repaid | - | -51.53 | - | - | -22.5 | -50 | Upgrade
|
| Net Debt Issued (Repaid) | -7.86 | -20.39 | - | - | -22.5 | 20 | Upgrade
|
| Issuance of Common Stock | 88.17 | 17.26 | 13.62 | 30.12 | 6.69 | 39.32 | Upgrade
|
| Repurchase of Common Stock | -1.1 | -0.01 | -0 | -0.01 | -0.1 | -2.83 | Upgrade
|
| Other Financing Activities | 8.14 | 7.11 | -2.03 | - | 44.37 | -6.89 | Upgrade
|
| Financing Cash Flow | 87.35 | 3.97 | 11.59 | 30.11 | 28.46 | 49.6 | Upgrade
|
| Net Cash Flow | 52.98 | -3.4 | -0.75 | -3.78 | -17.52 | -11.27 | Upgrade
|
| Free Cash Flow | -34.37 | -7.38 | -10.84 | -33.89 | -45.98 | -60.87 | Upgrade
|
| Free Cash Flow Margin | -58.36% | -14.58% | -22.74% | -66.67% | -100.28% | -115.71% | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.12 | -0.22 | -0.89 | -1.37 | -2.40 | Upgrade
|
| Cash Interest Paid | 7.34 | 4.6 | 6.44 | 6.44 | 8.49 | 7.34 | Upgrade
|
| Levered Free Cash Flow | -12.32 | -16.22 | -21.29 | -28.1 | -17.27 | -42.54 | Upgrade
|
| Unlevered Free Cash Flow | -12.24 | -13.53 | -13.73 | -17.8 | -11.72 | -38.64 | Upgrade
|
| Change in Net Working Capital | 5.58 | 7.16 | -8.15 | 5.18 | -5.42 | 15.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.